Clinical Trials Directory

Trials / Completed

CompletedNCT03807661

Percutaneous Deep Vein Arterialization Post-Market Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
LimFlow SA · Industry
Sex
All
Age
21 Years – 95 Years
Healthy volunteers
Not accepted

Summary

The objective of this post-market study is to evaluate the safety and effectiveness of the LimFlow System in creating a below-the-knee arterio-venous fistula for venous arterialization in subjects with critical limb ischemia.

Detailed description

This study will investigate the safety and effectiveness of the LimFlow System for creating an arterio-venous fistula in the below-the-knee vascular system using an endovascular, minimally invasive approach for the treatment of critical limb ischemia in subjects ineligible for conventional endovascular or surgical limb salvage procedures.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous deep vein arterializationCreation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach
DEVICELimFlow SystemCreation of an arterio-venous fistula in the below-the-knee vasculature using the LimFlow System endovascular, minimally invasive approach

Timeline

Start date
2019-12-11
Primary completion
2023-10-09
Completion
2024-10-28
First posted
2019-01-17
Last updated
2026-01-16
Results posted
2025-11-28

Locations

6 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03807661. Inclusion in this directory is not an endorsement.